盘龙药业：9月19日召开董事会会议

Group 1 - The core viewpoint of the article is that Panlong Pharmaceutical held its first board meeting of the fifth session on September 19, 2025, to discuss the appointment of the board secretary and other related documents [1] - For the first half of 2025, Panlong Pharmaceutical's revenue composition was as follows: pharmaceutical manufacturing and sales accounted for 99.34%, other products accounted for 0.52%, and health products accounted for 0.14% [1] - As of the report date, Panlong Pharmaceutical's market capitalization was 3.2 billion yuan [1]